Why do we need a statin trial in hemodialysis patients?

This publication has 16 references indexed in Scilit:

• Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective study
  The Lancet, 2001
• Inflammation, not hyperhomocysteinemia, is related to oxidative stress and hemostatic and endothelial dysfunction in uremia
  Kidney International, 2001
• Epidemiological evaluation of known and suspected cardiovascular risk factors in chronic renal impairment
  American Journal of Kidney Diseases, 2001
• Impaired endothelium‐dependent vasodilatation in renal failure in humans
  Nephrology Dialysis Transplantation, 2001
• Premature cardiovascular disease in chronic renal failure
  The Lancet, 2000
• Strong association between malnutrition, inflammation, and atherosclerosis in chronic renal failure
  Kidney International, 1999
• Clinical epidemiology of cardiovascular disease in chronic renal disease
  American Journal of Kidney Diseases, 1998
• Atherogenic lipoprotein changes in the absence of hyperlipidemia in patients with chronic renal failure treated by hemodialysis
  Atherosclerosis, 1997
• Outcome and risk factors of ischemic heart disease in chronic uremia
  Kidney International, 1996
• Enhanced LDL oxidation in uremic patients: An additional mechanism for accelerated atherosclerosis?
  Kidney International, 1994